AddLife AB
STO:ALIF B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AddLife AB
STO:ALIF B
|
SE |
|
Biotage AB
STO:BIOT
|
SE |
|
F
|
Forise International Ltd
SGX:8A1
|
SG |
|
MedCap AB (publ)
STO:MCAP
|
SE |
|
D
|
DB Energy SA
WSE:DBE
|
PL |
|
Chitose Internasional Tbk PT
IDX:CINT
|
ID |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ALIF B's stock price target?
Not Available
ALIF B doesn't have any price targets made by Wall Street professionals.
What is AddLife AB's Revenue forecast?
Projected CAGR
6%
For the last 8 years the
compound annual growth rate for
AddLife AB's revenue is
21%.
The projected
CAGR
for the next 3 years is
6%.
What is AddLife AB's Operating Income forecast?
Projected CAGR
-52%
For the last 8 years the
compound annual growth rate for
AddLife AB's operating income is
67%.
The projected
CAGR
for the next 3 years is
-52%.
What is AddLife AB's Net Income forecast?
Projected CAGR
-56%
For the last 8 years the
compound annual growth rate for
AddLife AB's net income is
75%.
The projected
CAGR
for the next 3 years is
-56%.
